Mono-therapy vs Polytherapy: When is Two Better Than One?
/
In the last issue of this magazine we focused on the relative attractiveness of the “old” medications for migraine treatment compared to the newer “designer drugs”…
Read More
Latest News
What’s New? Developments from the front lines of migraine research
/
Atogepant (Qulipta): an attractive new option for suppressing chronic migraine
Migraine “Rescue”: don’t like self-injection? how about a nasal spray?
Alzheimer’s, Dementia and Migraine: where things presently stand
Migraine and Sex: an update and a stimulating(!) new avenue of research
Lagniappe: A Gift: The Chesapeake and Ohio (C&O) Canal
/
The Chesapeake and Ohio (C&O) Canal was conceived by George Washington, the ever-entrepreneurial Father of Our Country, as a means of…
Read MoreMigraine Treatment of the Month: Divalproex sodium: an oldie... but a goodie?
/
In 1978 valproic acid (also known as sodium valproate or divalproex sodium) was approved by the FDA for seizure prevention…
Read MoreMigraine Myth of the Month: The triptans are potentially dangerous drugs
/
The first “designer drug” for migraine treatment, injectable sumatriptan (Imitrex), was approved by the FDA for general clinical use in this country in 1992…
Read MoreDoctor on Call: What the heck is “transformed migraine”?
/
Sandra, a 37-year-old computer software engineer and mother of three from Colorado Springs, writes:
Read MoreBiographies
/It is my great pleasure to announce to our readership that Drs. Robert Cowan and Richard Lipton have accepted my invitations to become senior editorial advisers.
Read MoreMessages to the Editor
/
Addressing the article entitled “Migraine’s Supply/Demand Problem” in our Spring 2022 issue Ms. Pam Nice writes…
Read MoreLetter from the Editor
/
After a gorgeous spring, western Maryland gave way to an equally gorgeous summer…
Read MoreMigraine’s “Supply:Demand” Problem...and How to Fix it: A public health bottleneck
/
Very few chronic medical disorders exert more…
Read MoreNon-Pharmacologic Treatment of Migraine: What YOU can do to reduce your migraine burden
/
Many of the newer medications for prevention of episodic migraine, suppression of chronic migraine and treatment of acute migraine headache are…
Read MoreMigraine Myth of the Month: Every Migraineur Needs to See a Healthcare Provider?
/
For a number of reasons I’ve long have had a problem reading papers published in the medical literature…
Read MoreMigraine Tip of the Month: Assess and Reduce Your Level of Stress
/
In this issue we have focused a fair amount of attention on how stress and migraine may interact…
Read MoreDoctor on Call
/
Janet, a 37-year-old female legal assistant and married mother of three who lives in Charlotte writes…
Read MoreLetter from the Editor
/
If you’re like me, Spring 2022 may be a time marked by cautious optimism uneasily blended with a grim sense of foreboding…
Read More
What is the “Best” Migraine Therapy? Old vs New, New vs New
/
While 2021 was replete with a variety of woes that any sane person would prefer…
Read MoreMigraine Treatment of the Month: Atogepant (Qulipta)
/
The nervous system is a complex collection of interactive electronic circuits that conduct…
COVID: Its Impact on Migraine and Migraine Management
/
...the ripples of COVID are reaching out to touch even far distant shores.
Read MoreDoctor on Call
/
Rachel, a 35-year-old female who lives in Washington, D. C. and works as project manager for one of the city’s countless nonprofit NGOs writes…
Read More
